Can retatrutide cause dizziness?

This site's retatrutide studies do not report dizziness as a measured result. What they do report on feeling is dysesthesia, an odd tingling or numb feeling in the skin. It showed up in about 12.5% of people on the 12 milligram dose in TRIUMPH-1. That study had 2,339 people, who lost up to 28.3% of their weight on average at 80 weeks, versus 2.2% on a dummy shot. Tingling is a skin-feeling finding, not a count of dizziness. Stomach and gut effects are the pattern for this drug family. This FAQ does not invent a dizziness rate from that skin-feeling finding.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.